Drug metabolism and pharmacokinetics (DMPK) examine how therapeutic compounds are absorbed, distributed, metabolized, and eliminated by the body. Early-stage in vitro and in vivo assessments of ADME properties are vital for identifying and refining lead compounds and for enabling a smooth transition into advanced preclinical and clinical studies.

Axiocell delivers end-to-end DMPK solutions tailored to the needs of modern drug development. Our expertise spans the characterization of physicochemical properties, formulation strategies, dosing regimens, selection of relevant animal models, routes of administration, and customized bioanalytical methodologies to ensure comprehensive support at every stage of the discovery pipeline.